The medical world has taken a revolutionary step forward with the approval of ELEVIDYS, the first gene therapy for treating Duchenne Muscular Dystrophy (DMD). Developed by Sarepta Therapeutics, this innovative treatment targets the underlying cause of DMD, providing hope to countless patients affected by this devastating disorder. This article delves into the FDA approval of ELEVIDYS,...

  The CAR-T Treatment Market has gained substantial attention in the field of oncology, offering groundbreaking solutions for treating aggressive and treatment-resistant cancers. Chimeric Antigen Receptor T-cell (CAR-T) therapy modifies a patient's own T-cells to identify and destroy cancer cells effectively. With multiple therapies already approved and ongoing clinical trials showing...

  Schizophrenia is a chronic and debilitating mental disorder characterized by symptoms such as hallucinations, delusions, disorganized thinking, and emotional withdrawal. It significantly impairs an individual's ability to function and affects millions of people worldwide. Despite decades of research, treatment remains challenging due to the disorder's complex nature and varied symptom...